Pulmonology

Papers
(The H4-Index of Pulmonology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Smoking-attributable mortality in Portugal and its regions in 2019308
Disease burden, comorbidities and antecedents of chronic cough phenotypes in Australian adults222
Assessment of the underreporting of rhinitis in patients with asthma: A MASK-air® real-world study201
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study. Authors’ reply146
Development and evaluation of spirometry reference equations at high altitude56
Complete response to mTOR inhibitor following JAKi failure in severe pulmonary sarcoidosis: Authors’ reply46
The Legend score synthesizes Wells, PERC, Geneva, D-dimer and predicts acute pulmonary embolism prior to imaging tests44
Smoking exposure trajectories and pulmonary function in early adulthood in a Brazilian cohort42
“Alveolar stem cell exhaustion, fibrosis and bronchiolar proliferation” related entities. A narrative review42
Weaning from tracheostomy: Trend of decannulation rate over two decades in a respiratory rehabilitation centre42
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study36
In-hospital mortality of high-risk pulmonary embolism: a nationwide population-based cohort study in Portugal from 2010 to 201836
Issue 3—The occupational burden of respiratory diseases, an update35
Low tumour interleukin-1β expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study34
Clusters of individuals recovering from an exacerbation of chronic obstructive pulmonary disease and response to in-hospital pulmonary rehabilitation33
For a patient with severe asthma, every day may be his last World Asthma Day31
Noninvasive ventilatory support in morbid obesity30
Late-onset Pompe disease (LOPD): May axial myopathy influence respiratory dysfunction?29
Continuous noninvasive ventilatory support outcomes for patients with neuromuscular disease: a multicenter data collaboration29
Mepolizumab in severe asthma exacerbation in a respiratory ICU—a successful off-label use28
Effect of elexacaftor–tezacaftor–ivacaftor modulator on lung structure in cystic fibrosis28
Nontuberculous Mycobacteria in Portugal: Trends from the last decade27
Assisted mobilisation in critical patients with COVID-1925
Tuberculosis and risk of Parkinson's disease: A nationwide cohort study25
0.10580205917358